Social Media Ideas for Amgen Inc

Amgen Reports Theft of Patient Data in Cyber Incident

Amgen Inc. experienced a cyber incident that involved the theft of patient information and proprietary data stored in cloud servers, it said in a filing July 31, the latest large h...

Amgen Settles Shareholder Lawsuit Claiming it Hid $10.7 Billion Tax Bill

Amgen reached a $74 million settlement of a lawsuit accusing the biotechnology company of waiting too long to disclose that it might owe the Internal Revenue Service $10.7 billion...

Amgen, Sanofi Team Up To Urge En Banc Antibody IP Review

Rival pharmaceutical companies that squared off at the U.S. Supreme Court over antibody patents have jointly asked the full Federal Circuit to review an unrelated panel decision re...

Amgen’s $74 Million Securities Deal Puts Tax Disclosure Timing in Focus

Amgen has agreed to pay $74 million to resolve a shareholder class action in the Southern District of New York alleging the company waited too long to disclose a potential IRS tax...

Amgen’s $74 Million Securities Deal Puts Tax Disclosure Timing in Focus

Amgen has agreed to pay $74 million to resolve a shareholder class action in the Southern District of New York alleging the company waited too long to disclose a potential IRS tax...

EMA: Amgen, Vifor Inflammatory Drug’s Benefits No Longer Outweigh Risks

A European Medicines Agency committee now recommends withdrawing marketing authorization for Tavneos, an Amgen drug marketed in Europe by a CSL Limited subsidiary. Meanwhile, an FD...

Amgen sheds around 40 staffers amid continuing struggles

Amgen has laid off around 40 employees as part of “organizational changes” meant to better align operations with the company’s strategic objectives, Fierce has learned.

Amgen lays groundwork for new R&D center in Hyderabad

Amgen is expanding its footprint in India with an R&D center in Hyderabad, the latest by from the California company to boost its research facilities.

Amgen results show biosimilars and IRA pricing reshaping drug spend

Two forces now hitting pharma revenues, and both carry direct implications for employer health plans

Bloomberg: Amgen Settles Investor Suit Over Tax Liability for $74 Million

Gillian R. Brassil (Bloomberg): Amgen Settles Investor Suit Over Tax Liability for $74 Million: Amgen Inc. agreed to cough up $74 million to resolve allegations that the pharmaceut...

Amgen: Marketing Director, Bone IMPACT, US Bone Health Business Unit

Headquarters: US - California - Thousand Oaks URL: http://amgen.com Career CategoryMarketingJob DescriptionWhat you will doLet's do this. Let's change the world. At Amgen, ou...

After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset

Spero Therapeutics enters immunology with an antibody licensed from Innovent Biologics. The lead indication is a rare autoimmune condition where Spero aims to offer advantages over...

Layoffs

Layoffs Anonymous (not verified) Mon, 07/20/2026 - 15:19 field_thread_url https://cafepharma.com/boards/threads/layoffs.716278/ board na...

Layoffs

Layoffs Anonymous (not verified) Tue, 07/21/2026 - 15:20 field_thread_url https://cafepharma.com/boards/threads/layoffs.716278/ board na...

Amgen says cloud data breach exposed patient health, proprietary info

Pharmaceutical company Amgen says it suffered a data breach after threat actors stole corporate data and patient information stored in multiple cloud systems operated by third-part...

FDA Approves Viridian’s Thyroid Eye Disease Drug, Competitor to a Blockbuster Amgen Med

Viridian Therapeutics’ Lumvoa is approved for treating both the chronic and active phases of thyroid eye disease. This drug will offer patients an alternative to Tepezza, an Amgen...

I work at amgen. ask me anthing. I'll answer honestly

I work at amgen. ask me anthing. I'll answer honestly Anonymous (not verified) Tue, 07/07/2026 - 09:09 field_thread_url https://cafepharma.com/boards/threa...

Amgen discloses data breach, says patient information was stolen

<![CDATA[Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb]]&...

Pomerantz LLP Calls Attention to Class Action Against ADMA Biologics, Inc. – ADMA

ANC

ANC Anonymous (not verified) Tue, 08/04/2026 - 21:28 field_thread_url https://cafepharma.com/boards/threads/anc.712901/ board name...

Sandoz's Patent Loss Blocks Antitrust Suit, 4th Circ. Told

Retired U.S. Circuit Judge Paul R. Michel is backing Amgen against Sandoz's Fourth Circuit appeal, arguing in an amicus brief that the final say over now-nixed allegations of block...

Pomerantz LLP Calls Attention to Class Action Involving ADMA Biologics, Inc. – ADMA

Pomerantz LLP Calls Attention to Class Action Filed Against ADMA Biologics, Inc. – ADMA